SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-015570
Filing Date
2022-08-08
Accepted
2022-08-08 16:32:03
Documents
60
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q avir-20220630.htm   iXBRL 10-Q 2341027
2 EX-10.1 avir-ex10_1.htm EX-10.1 38889
3 EX-10.2 avir-ex10_2.htm EX-10.2 78244
4 EX-31.1 avir-ex31_1.htm EX-31.1 17794
5 EX-31.2 avir-ex31_2.htm EX-31.2 18073
6 EX-32.1 avir-ex32_1.htm EX-32.1 12615
7 EX-32.2 avir-ex32_2.htm EX-32.2 11805
  Complete submission text file 0000950170-22-015570.txt   6185654

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avir-20220630.xsd EX-101.SCH 36515
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avir-20220630_cal.xml EX-101.CAL 34153
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avir-20220630_lab.xml EX-101.LAB 285460
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avir-20220630_pre.xml EX-101.PRE 198150
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avir-20220630_def.xml EX-101.DEF 100759
54 EXTRACTED XBRL INSTANCE DOCUMENT avir-20220630_htm.xml XML 797897
Mailing Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110
Business Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Filer) CIK: 0001593899 (see all company filings)

IRS No.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39661 | Film No.: 221144871
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences